Literature DB >> 34423091

The Value of the Distal Radioulnar Joint Effusion in Diagnosing Triangular Fibrocartilage Complex Tears on Magnetic Resonance Imaging.

Caitlin M Brennan1, Li Yenn Yong1, Jon Foley2, Scott McKie2, Philippa A Rust1.   

Abstract

BACKGROUND: A retrospective study was conducted to evaluate the role of distal radioulnar joint (DRUJ) effusion in aiding the diagnostic accuracy of central triangular fibrocartilage complex (TFCC) tears on non-contrast MRI.
METHODS: 89 consecutive patients who had undergone wrist arthroscopy for ulna sided wrist pain in our unit were identified and their preoperative imaging reviewed. Two consultant musculoskeletal Radiologists independently reported the presence or absence of a DRUJ effusion and or a TFCC tear. The inter-observer variability was calculated using weighted Kappa tests. Two by two tables were constructed to calculate the sensitivity and specificity of reported TFCC tear or DRUJ effusion on MRI in correctly diagnosing central TFCC tears identified at arthroscopy.
RESULTS: Sensitivity of MRI to report a TFCC tear was 0.56 and specificity was 0.79. Sensitivity increased to 0.89 if either a DRUJ effusion or TFCC tear were seen on MRI. When observed together, the presence of both a DRUJ effusion and a TFCC tear seen on the imaging lead to a sensitivity of 0.74 and PPV of 82% when compared to findings at arthroscopy. In the absence of both DRUJ effusion and TFCC tear, the specificity of MRI increased to 0.92. Agreement by the radiologists on the presence of DRUJ effusion was substantial (k value 0.67) and TFCC tear was moderate (k value 0.58).
CONCLUSION: The presence of DRUJ effusion on MRI can further improve sensitivity of MRI in diagnosing central TFCC tears. The sensitivity of detecting a central TFCC tear on MRI scan when both a DRUJ effusion and a TFCC tear were seen (0.74) is comparable to rates demonstrated on MRA meta-analysis results (0.78). Furthermore, considering the absence of both a DRUJ effusion and TFCC tear seen on MRI is useful in excluding the presence of a TFCC tear at arthroscopy.

Entities:  

Keywords:  Arthroscopy; Triangular fibrocartilage complex; Wrist injuries

Year:  2021        PMID: 34423091      PMCID: PMC8359651          DOI: 10.22038/abjs.2020.48520.2464

Source DB:  PubMed          Journal:  Arch Bone Jt Surg        ISSN: 2345-461X


  7 in total

Review 1.  Top-Ten Tips for Imaging the Triangular Fibrocartilaginous Complex.

Authors:  Alex W H Ng; Cina S L Tong; Esther H Y Hung; James F Griffith; W L Tse; Clara W Y Wong; Michael C K Mak; P C Ho
Journal:  Semin Musculoskelet Radiol       Date:  2019-06-06       Impact factor: 1.777

2.  TFCC Injuries: Meta-Analysis and Comparison of Diagnostic Imaging Modalities.

Authors:  Matthew D Treiser; Kayva Crawford; Matthew L Iorio
Journal:  J Wrist Surg       Date:  2018-02-14

Review 3.  Diagnostic accuracy of magnetic resonance imaging and magnetic resonance arthrography for triangular fibrocartilaginous complex injury: a systematic review and meta-analysis.

Authors:  Toby O Smith; Benjamin Drew; Andoni P Toms; Christina Jerosch-Herold; Adrian J Chojnowski
Journal:  J Bone Joint Surg Am       Date:  2012-05-02       Impact factor: 5.284

Review 4.  A Systematic Review of Outcomes after Arthroscopic Débridement for Triangular Fibrocartilage Complex Tear.

Authors:  Taichi Saito; Sunitha Malay; Kevin C Chung
Journal:  Plast Reconstr Surg       Date:  2017-11       Impact factor: 4.730

Review 5.  Prevalence of triangular fibrocartilage complex abnormalities regardless of symptoms rise with age: systematic review and pooled analysis.

Authors:  Jimmy J Chan; Teun Teunis; David Ring
Journal:  Clin Orthop Relat Res       Date:  2014-08-05       Impact factor: 4.176

6.  Ulnar-sided wrist pain. II. Clinical imaging and treatment.

Authors:  Atsuya Watanabe; Felipe Souza; Peter S Vezeridis; Philip Blazar; Hiroshi Yoshioka
Journal:  Skeletal Radiol       Date:  2009-12-10       Impact factor: 2.199

7.  Interrater reliability: the kappa statistic.

Authors:  Mary L McHugh
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.